Amendment Statement of Principles

concerning

MYELOMA

No. 72 of 2014

for the purposes of the

Veterans’ Entitlements Act 1986

and

Military Rehabilitation and Compensation Act 2004

1. This Instrument may be cited as Amendment Statement of Principles concerning myeloma No. 72 of 2014.
2. In accordance with the Specialist Medical Review Council Declaration No. 23 of 12 May 2014 under subsection 196W(4) of the Veterans’ Entitlements Act 1986 (the VEA), the Repatriation Medical Authority amends, pursuant to subsection 196B(10) of the VEA, Statement of Principles concerning myeloma Instrument No. 69 of 2012, by:
   1. Inserting additional factor "(da)" immediately following factor "(d)" in clause 6 as follows:

"(da) having exposure to 2,3,7,8 tetrachlorodibenzo-para-dioxin (TCDD) sufficient to produce an expected initial serum TCDD level of at least 1 500 parts per trillion before the clinical onset of myeloma; or".

3.                     The amendment made by this instrument applies to all matters to which Instrument No. 69 of 2012, section 120A of the Veterans’ Entitlements Act 1986 and section 338 of the Military Rehabilitation and Compensation Act 2004 apply.

4.                     The amendment made by this instrument takes effect from 13 May 2014.

Dated this  twentieth   day of   June   2014

The Common Seal of the  )

Repatriation Medical Authority )

was affixed at the direction of: )

PROFESSOR NICHOLAS SAUNDERS AO

CHAIRPERSON